The pandemic has created a lot of disruption in clinical trials, but not all of it has been negative. From accelerating the adoption of decentralized trials and speeding up the delivery of vaccines, to telemedicine and mHealth playing bigger roles in patients’ lives, opportunities have emerged to help us rediscover and recalibrate the way we perform clinical research. Many believe we can’t go back to the old way of doing things – so who’s leading the charge?
In this episode, we define what a movement is, learn how to be the “Dancing Man,” and discuss why the #NoGoingBack mission is so critical to preserving the progress and innovation we’ve made in clinical research. To talk about why this is so important, we brought two leaders of the #NoGoingBack movement on to share what it means to them. First, we have Co-Chair Maimah Karmo, someone who has survived war, being a refugee, and breast cancer, and now dedicates her life to educating, advocating for, empowering, and supporting young women of diverse ethnic backgrounds affected by breast cancer through her non-profit advocacy organization, the Tigerlily Foundation.
Next, we have #NoGoingBack Co-Chair Craig Lipset, a leader in this industry who is also the advisor and founder of Clinical Innovation Partners, the co-chair for the Decentralized Trials & Research Alliance (DTRA), and an adjunct professor at Rutgers and Rochester Center for Health.
A movement needs more than one person to be successful. If you believe the progress we’ve made in conducting clinical trials and other aspects of clinical research needs to continue, pledge your support!
To connect with the Tigerlily Foundation on social, make sure to follow them on Twitter, Facebook, Instagram, and LinkedIn. To connect with Maimah and hear more about her story, you can find her on Twitter, LinkedIn, or her website.
You can listen to the conversation by going to The Latest Dose.
Don’t forget to check out our other episodes, and make sure to subscribe!